Noom Introduces Oral Medications for Cost-Effective Weight Loss

January 16, 2025

Noom, a prominent name in digital health known for its focus on chronic disease prevention, has recently announced the inclusion of oral medications within its Noom Med program. Noom Med was launched to expand the company’s efforts in building healthier habits through psychological tools, food tracking, coaching, and community support. By introducing oral medications, Noom aims to provide a comprehensive weight loss solution accessible to a more extensive range of users. This strategic move is expected to benefit people unable to use GLP-1 injections due to needle aversions or those who do not meet the BMI criteria for such treatments.

Expanding Noom Med With Oral Medications

The Role of Metformin in Weight Loss

The introduction of oral medications marks a significant enhancement to Noom Med’s offerings. The first oral medication to be introduced is Metformin, a drug traditionally used to manage type 2 diabetes. Metformin’s off-label use for weight loss is supported by its ability to reduce appetite and increase insulin sensitivity—a dual benefit aiding weight management. This particular medication is available as a 500mg daily tablet, initially priced at $29 for the first month. Subsequent costs are $89 per month for those on a three-month recurring subscription.

One of the critical advantages Metformin brings is cost efficiency. Compared to Noom’s GLP-1 prescription plan, where compounded semaglutide starts at $149 per month, Metformin presents a more affordable entry into medically-aided weight loss. The GLP-1 plan also extends access to brand-name medications like Ozempic from $69 per month, albeit additional out-of-pocket expenses may apply depending on insurance coverage. Noom’s CEO, Geoff Cook, highlights that the affordability of Metformin, a widely available generic drug, aligns with Noom’s mission of making effective weight loss treatments more accessible.

An Alternative for Users With Needle Aversion

The addition of oral medications specifically addresses the needs of users who are either needle-averse or do not meet the specific BMI criteria required for GLP-1s. In doing so, Noom broadens the appeal and versatility of its Noom Med program, reaching out to a more diverse population seeking effective weight management solutions. Users who prefer oral medications can still benefit from Noom Med’s integrated approach, which combines medication with comprehensive behavior change support.

To initiate the process, Noom members must complete an intake survey followed by a clinician consultation. If the clinician determines Metformin to be appropriate, the prescription is confirmed, and the medication is dispatched directly to the user. Upon obtaining Metformin, users gain access to the additional features offered by Noom Med. These include asynchronous telehealth services, care coordinators, and one-on-one coaching, ensuring a well-rounded support system for their weight loss journey.

Addressing Affordability and Accessibility

Cook’s Advocacy for Reducing Prescription Drug Costs

Geoff Cook’s vision extends beyond merely offering affordable weight loss options. He has been vocal about the need for a broader conversation around reducing the cost of prescription drugs in the United States. Cook suggests empowering the FDA to create a public High-Cost Drug Database to monitor excessively high-priced medications compared to the global average. Such a database could potentially open doors for FDA-regulated facilities to produce compounded versions of these medications at a lower cost. This market-driven solution aims to democratize access to essential drugs, making healthcare more equitable.

The inclusion of oral medications in Noom Med’s lineup exemplifies Cook’s and Noom’s dedication to making health improvements both affordable and achievable for a vast population. By addressing cost and accessibility, Noom strengthens its commitment to aiding individuals in forming healthier habits through comprehensive, multi-faceted support.

Comparison to Other Weight Loss Medication Providers

Noom, a leading figure in the digital health industry, renowned for its emphasis on chronic disease prevention, has made a significant announcement concerning its Noom Med program. This program, initially designed to foster the development of healthier habits through psychological tools, food tracking, coaching, and community support, will now include oral medications. The introduction of these medications signifies a strategic expansion aimed at offering a holistic weight loss solution to a broader user base. This move is particularly beneficial for individuals who cannot use GLP-1 injections due to a fear of needles or who do not meet the body mass index (BMI) requirements for such treatments. By incorporating oral medications, Noom intends to make weight loss solutions more inclusive and accessible, further solidifying its position in the field of digital health and chronic disease prevention. With this expanded approach, Noom continues to innovate and address diverse needs within the realm of health and wellness.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later